Showing results (1-10 of 2,403) with videos related to

Sort By:
Pageof 241
Brain and Behavior|October 16, 2025
Causal Relationship Between Anxiety Disorders and Cancers: A Bidirectional Two-Sample Mendelian Randomization StudyJingyang Su, Jialin Zhang, Jue Wang
European Journal of Clinical Pharmacology|July 7, 2025
A meta-analysis and systematic review of the first Trop-2-targeting antibody-drug conjugate (sacituzumab govitecan) in treating metastatic breast cancerJue Wang, Shengyou Lin, Jialin Zhang, et al.
Frontiers in Oncology|March 19, 2025
A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancerJialin Zhang, Xinyu Xu, Yeyue Zhou, et al.
Expert Review of Anticancer Therapy|March 29, 2024
Comparative efficacy and safety of cabozantinib for malignant tumors: a systematic review and meta-analysisJingyang Su, Cui Ni, Yuqian Wu, et al.
Future Oncology (London, England)|November 20, 2024
Comparative efficacy and safety of eribulin versus paclitaxel in breast cancer: a systematic review and meta-analysisJialin Zhang, Jingyang Su, Cui Ni, et al.
Genes, Brain, and Behavior|June 18, 2026
Exploring the Association Between Mental Disorders and Various Arrhythmias via Mendelian Randomization MethodsJingyang Su, Jialin Zhang, Yueyue Ding, et al.
Expert Review of Anticancer Therapy|July 6, 2024
Evaluating the efficacy and safety of trebananib in treating ovarian cancer and non-ovarian cancer patients: a meta-analysis and systematic reviewJialin Zhang, Jingyang Su, Yeyue Zhou, et al.
Journal of Affective Disorders|September 23, 2024
Association of anxiety disorder, depression, and bipolar disorder with autoimmune thyroiditis: A bidirectional two-sample mendelian randomized studyJingyang Su, Jialin Zhang, Hanyu Zhu, et al.
Frontiers in Pharmacology|May 2, 2024
Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysisJingyang Su, Jialin Zhang, Yuqian Wu, et al.
Current Opinion in Oncology|February 1, 2023
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?Jingyang Su, Jinhua Lu, Jialin Zhang, et al.
Pageof 241